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Patients were eligible if they were  18 years of age. Patients with
atrial ﬁbrillation, contraindication to iodinated contrast agents, and
serum creatinine values >1.4 mg/dl were excluded.
Coronary angiography was performed using standard 6Fr coronary
catheters through trans-femoral or trans-radial approach. Coronary
angiograms were evaluated by 2 experienced, independent observers.
Coronary arteries were segmented according to guidelines of the
American Heart Association 18 (modiﬁed 16-segment model, with
segment 17 being intermediated branch of the left coronary artery).
12 patients were investigated by MSCT (Philips, 64 Slice, Philips,
USA). After determination of the contrast agent transit time, a volume
dataset was acquired (collimation 2640.6 mm, z-ﬂying focal spot,
gantry rotation time ms, tube current 400mAs/rotation, tube voltage
120kV) without application additional b-blocker medication to control
heart rate. Contrast agent (60 to 80 ml, iodine 350 mg/ml) was injected
at a ﬂow rate of 5 ml/s. All scans were performed using electrocar-
diographically gated tube current modulation. Maximal tube current
was limited to an interval 30% to 70% of cardiac cycle. Trans-axial
images were reconstructed with 0.75-mm slice thickness, 0.5-mm
increment, and a medium soft convolution kernel (B26f). The position
of the reconstruction window within the cardiac cycle was individu-
ally selected to minimize motion artifacts. The best dataset was used
for subsequent analysis.
RESULTS In total, 16 consecutive patients (75%men, mean ages
65years) with coronary artery diseases who underwent coronary
angiography were included in the study. Six cases of single coronary
artery (SCA) were found: including three cases of anomalous right
coronary artery (RCA) originating from the proximal or mid of left
descending coronary artery; left main coronary artery (LMCA) arising
from the proximal right coronary artery one case; anomalous RCA
originating from the distal of left circumﬂex (LCX) artery two cases.
Ten cases of anomalous RCA were detected: including anomalous RCA
arising from anterior wall of ascending aorta six cases and left sinus of
Valsalva four cases respectively. Multi-slice computed tomography
(MSCT) detected the origin and course of the anomalous coronary
artery in 12 of 16 patients (75%).
CONCLUSION Coronary angiography is essential detecting methods
to ﬁnd coronary anomalies and MSCT clearly depict the origin and
course of the anomalous coronary artery.
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Primary PCI with “Single” Catheter
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BACKGROUND The beneﬁt of primary percutaneous coronary inter-
vention (PCI) for acute ST segment elevation myocardial infarction
(STEMI)is well documented and is closely tied to the door to balloon
(DTB) time. To shorten the DTB time, we perform diagnostic angiog-
raphy with IL-4.0 guiding catheter (Heartrail, Terumo Corporation,
Tokyo, Japan) because we can switch to the primary PCI immediately
following the full coronary angiogram with a single catheter.
METHODS We studied consecutive 31 STEMI patients who underwent
primary PCI at our hospital from November 1st 2013 to November 15th
2014. All patients were radial artery approach and the patients with
shock vital were excluded. Eight patients were performed diagnostic
angiography withIL-4.0 (IL group), and other 23 patients were per-
formed with JL-4.0, and JR-4.0(standard group). The cath lab to ﬁrst
device time was calculated.
RESULTS The cath lab to ﬁrst device time was signiﬁcantly faster in IL
group comparedwith standard group (19.5min vs. 38.3min, p¼0.0001).
CONCLUSION For STEMI patients, IL-4.0 catheter angiography
shortens the DTB time and may improve the patients’ outcome.
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Acute Complications Following Balloon Mitral Valvuloplasty – Analysis of
1450 Cases over 15-Year Period
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India; 2Chesterﬁeld Royal Hospital, United KingdomBACKGROUND Balloon mitral valvuloplasty (BMV) has in vogue for
more than 3 decades. The complications of the procedure are well
known. Few studies have analyzed the complications and its out-
comes following BMV in a large cohort.
METHODS Single center retrospective data analysis of acute compli-
cations following BMV for 15years from 1998-2012.The study looked in
to immediate 30 day outcomes following BMV. The data were retro-
spectively collected from hospital records.
RESULTS Data was available in 1450 patients (females 986) who un-
derwent BMV. Mean age of patients was 23.7 years (SD 5.8) (range
9-57 years) with mean follow up period of 9.7 years (SD 4.6). Inter-
vention resulted in successful BMV (more than 50% reduction in
baseline gradient) in 1294(94%) subjects and partially successful BMV
(20-50% reduction in baseline gradient) in 105 (6%) subjects. BMV
failed in 51 patients. Mitral regurgitation (MR) was observed in 76
patients (3.85%). But acute severe mitral regurgitation requiring
mitral valve replacement was noticed in 26 (1.79%) patients. On uni-
variate analysis female sex, age 40 years, eccentric valve calciﬁca-
tion and Wilkin’s score  10 were more frequent in patients who
developed acute MR. Moderate MR occurred in 37(2.55%) patients and
mild MR in 41 patients (2.81%). Cardiac tamponade occurred in 19
patients (1.23%). Mild pericardial effusion was seen in 26patients and
BMV was deferred in the three of these patients. New onset atrial
ﬁbrillation was encountered in 14 (1.018%) patients during and
immediately after BMV. Five patients (0.3%) developed cerebrovas-
cular accident with signiﬁcant neurological deﬁcits following balloon
dilatation, which recovered gradually, and one patient had a transient
ischemic attack. Coiled wire got detached in the left atrium in one
patient and it was removed using a snare. There were 4 deaths. One
patient with severe RV dysfunction died on table. Another patient
died a week after failed BMV. Two patients died within a month of the
procedure due to non-cardiac illness. Vascular complications occurred
in 16 patients (1.1%) with retroperitoneal hematoma in one patient and
12 patients having groin hematoma. Femoral AV ﬁstula developed in
one patient, which required prolonged local compression. 2patients
had profunda artery pseudo aneurysm managed with local
embolization.
CONCLUSION The study shows excellent 30 -day outcomes for
balloon mitral valvuloplasty with mortality rate of 0.1%. Major mor-
bidities were acute severe MR (1.79%), cardiac tamponade (1.23%) and
vascular complications (1.1%). The occurrence of Atrial arrhythmias
and major strokes were noted at 1% and 0.3% respectively.
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BACKGROUND Rheumatic heart disease causes signiﬁcant morbidity
and mortality in many of Asian and African countries. The resultant
corrective surgery for valve necessitates mechanical prosthetic valve
implantation at an earlier age to these patients. Prosthetic valve im-
plantation has its inherent problems and needs a proper oral anti-
coagulation with targeted INR throughout the life. Stuck valve is one
of the major complications encountered in this set of patients who
have suboptimal anticoagulation or interrupted anticoagulant ther-
apy. Thrombotic occlusion and restriction of valve leaﬂet movements
in mechanical valves often requires redo procedure which carries high
surgical risk. Medically managing such patient with early thrombol-
ysis and optimization of anticoagulation negates the need for redo
procedure, if successful. Herewith we present a series of cases
managed with thrombolysis for stuck valve Rheumatic heart disease
patients.
METHODS This retrospective study analyzed 16 patients of Rheumatic
Heart disease who underwent prosthetic valve implantation in mitral
and aortic position and presented with stuck valve in our center since
2012.The age group ranged from 22 to 60 years with 6 males and 10
females. Patients commonly presented with worsening dyspnea of
NYHA class III to acute pulmonary edema. After initial stabilization all
patients underwent detailed echocardiographic evaluation and stuck
valve is diagnosed if there is restricted prosthetic valve mobility with
higher gradient across the valves. Visible thrombus and pannus, if
any, were noted. Doubtful cases had ﬂuoroscopic examination in
catheterization laboratory to ascertain valve movement restriction.
The last follow-up INR, detailed drug history, drug compliance,
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kinase was used as thrombolytic agent in all cases with loading dose of
150000 to 250000 units over 30 minutes followed by 100000 units per
hour over next 24 hours or till valve opens whichever is earlier.
Heparin was given prior to thrombolytic therapy and not continued
during thrombolytic therapy. Concomitant oral anticoagulation ther-
apy dose was optimized .Repeat echocardiographic examination was
performed at 6, 12 and 24 hours after initiation of therapy. Clinically,
reappearance of audible metallic click was monitored. Any bleeding
complications both minor and major and neurological worsening was
noted. Safety of thrombolysis is assessed by complications incurred,
directly related or as a consequence of thrombolytic therapy. Efﬁcacy
is assessed by clinical reappearance of metallic click, resumption of
leaﬂet movement in echocardiography and fall in the mean pressure
gradient across studied prosthetic valve.
RESULTS Stuck valve was managed with thrombolysis with strepto-
kinase in 16 patients of Rheumatic heart disease who have undergone
Prosthetic mechanical valve implantation. All but one had St Jude
bileaﬂet prosthesis as implant (size 27 – 28mm) . One patient had TTK
chitra valve implanted. Average time of stuck valve after surgery was
14 months. Stuck valve occurred in mitral position in all except one in
aortic position. Low INR at admission indicating suboptimal anti-
coagulation was the major cause of stuck valve which in turn was
mainly due to discontinuation of oral anticoagulant therapy. Acute
pulmonary edema was the most common presentation followed by
worsening class of dyspnea. Thrombolysis with streptokinase was
successful in restoring valve movements with fall in mean gradient in
94% of cases. Redo thrombolysis in successfully thrombolyzed patient
for stuck valve previously with same agent failed probably due to
development of antibodies. 2 patients developed stroke in the process
of thrombolysis which is of embolic origin and CT scan revealed no
hemorrhage. Minor bleeding was noted in 32% of cases in form of gum
bleeding and hematuria. No signiﬁcant allergic reactions encountered.
Overall thrombolysis was successful in majority of the cases with no
major life threatening complications. Thus streptokinase as a throm-
bolytic agent is deﬁnitely a low cost, safe and effective treatment
alternative for high risk redo surgical procedure in patients of stuck
valve in rheumatic heart disease.
CONCLUSION Stuck valve is the major complication in long run in a
patient of valvular heart disease who has undergone mechanical
prosthetic valve implantation. Early recognition and successful
thrombolysis is a safe and effective alternative to a more cumbersome
high risk redo valve surgery for such cases. Streptokinase is safe, cost-
effective thrombolytic agent for naive cases presenting with stuck
valve.
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BACKGROUND Rheumatic fever and rheumatic heart disease
continue to be the major health problem in all developing countries
including Bangladesh. Rheumatic mitral stenosis is a very common
problem in our population having an incidence of 54 percent among
rheumatic heart disease with a female preponderance of 2:1. Percu-
taneous balloon mitral commissurotomy is appealing because the
mechanism of valve dilation closely parallels the mechanism of sur-
gical mitral commissurotomy. The technique of balloon mitral com-
missurotomy has evolved rapidly, with improvements in balloons,
guide wires, and the application of double-balloon techniques.
Percutaneous transvenous mitral commissurotomy (PTMC) using an
Inoue balloon catheter is of established efﬁcacy and safety and is an
alternative to surgical valvotomy in selected patients with rheumatic
mitral stenosis. Mitral valve Wilkins echo score have shown to be an
important factor in determining immediate outcome of patients un-
dergoing surgical mitral commissurotomy. Patient selection has an
important impact on the outcome of percutaneous balloon mitral
commissurotomy.
METHODS A prospective study was done in National Institute of Car-
diovascular Diseases, Dhaka, Bangladesh and Al- Helal Heart Institute,
Mirpur, Dhaka during the period of August 2003 to June 2014. Nine
hundred and ninety (990) patients with rheumatic mitral stenosis who
underwent PTMC were evaluated clinically, by echocardiography and
by catheter during and after procedure. Out of 990 patients 60 patients
hadWilkins Echo score>8 (9-12) (Group-1) and rest 930 patients had low
and medium Wilkins Echo score < 8 (Group-2).RESULTS Mean age of the study population was 33.36  09.80 years
in group-1 and 23.14  11.21years in Group-2. Most of the population
are female, 70%in Group-1 and 78% ingroup-2.After PTMC mean
mitral valve area increased from 0.80  0.11 cm2to1.46  0.27 cm2 as
measured by echocardiography in group-1 and from 0.85  0.32 cm2 to
1.81  0.33 cm2in group-2. Mitral valve gradient reduced to 11.63 
4.15 mm Hg from 32.46  03.94 mm Hg after PTMC in group-1 and
10.45 3.76 mm Hg from 26.64  04.12 mm Hg after PTMC in group-2.
Mean left atrial pressure as recorded by catheter before PTMC was
33.99  08.37 mmHg while after PTMC it was 21.81  06.28mm Hg in
group-1 and 28.81  07.32 mm Hg while after PTMC it was 17.76 
05.11 mm Hg in group-2. High Wilkins Echo score group (Group-1) had
higher NYHA class, higher atrial ﬁbrillation and higher commissural
calcium score.
CONCLUSION Though PTMC is an effective procedure for patients
with high Wilkins score but result is inferior to patients with low and
medium echo score.TCTAP A-182
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BACKGROUND Rheumatic fever and rheumatic heart disease
continue to be the major health problem in all developing countries
including Bangladesh. Rheumatic mitral stenosis is a very common
problem in our population having an incidence of 54 percent among
rheumatic heart disease with a female preponderance of 2:1. Percu-
taneous balloon mitral commissurotomy is appealing because the
mechanism of valve dilation closely parallels the mechanism of sur-
gical mitral commissurotomy. The technique of balloon mitral com-
missurotomy has evolved rapidly, with improvements in balloons,
guide wires, and the application of double-balloon techniques. So, we
aimed to assess the immediate in-hospital complications of percuta-
neous transvenous mitral commissurotomy (PTMC) in patients with
symptomatic moderate to severe rheumatic mitral stenosis in our
population.
METHODS A prospective study was done in National Institute of
Cardiovascular Diseases, Dhaka, Bangladesh and Al- Helal Heart
Institute, Mirpur, Dhaka during the period of August 2003 to June
2014. Nine hundred and ninety (990) patients with rheumatic mitral
stenosis who underwent PTMC were evaluated clinically, by echo-
cardiography and by catheter during and after procedure.
RESULTS Mean age of the study population was 28.31  11.21 years.
Most of the populations are female (81%). After PTMC mean mitral
valve area increased from 0.83  0.11cm2 to 1.76  0.27 cm2 as
measured by echocardiography. Mitral valve gradient reduced to
11.63  4.15 mm Hg from 28.46  03.94 mm Hg after PTMC. Left atrial
size also decreased from 48.27  07.76 mm to 37.25  08.62 mm.
Mean left atrial pressure as recorded by catheter before PTMC was
30.99  08.37 mm Hg while after PTMC it was 13.81 06.28 mm Hg.
Mean aortic pressure increased from 91  04 mm Hg to 98  07 mm
Hg after the procedure. There was no procedural death. There were
4 patients in- hospital death. 2 patients died from massive CVD
after PTMC. 1 patient died from renal failure and electrolyte imbal-
ance, 1 patient died from multi system organ failure due to sepsis
unrelated to PTMC. There were 2þmitral regurgitation in 3 patients or
3þ post PTMC mitral regurgitation in 1 patient as assessed by left
ventriculography. There was no TCTAP A-V block during or after
PTMC.
Pericardial tamponade occurred in 5 patients post procedure and
those patients were successfully treated with pericardiocentesis in the
catheterization laboratory under echo guidance and PTMC was
completed successfully. Thromboembolic events occurred in 04 pa-
tients and in 2 patients massive CVD and in 2 patients TIA. Left to right
shunt (ASD) occurred in 30 patients. Local vascular complications like
pain, hemorrhage, hematoma occurred in 69 patients.
CONCLUSION PTMC is a very effective and safe procedure at relieving
the hemodynamic effects of rheumatic mitral stenosis. It is an alter-
native to closed mitral commissurotomy (CMC) and intervention of
choice of symptomatic rheumatic mitral stenosis with suitable mitral
valve morphology. Complications during the procedure were very few.
